Macmic Science&Technology Co.,Ltd.
SSE:688711.SS
16.23 (CNY) • At close May 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,331.36 | 1,503.263 | 926.084 | 550.636 | 331.629 | 259.721 | 262.493 | 209.175 | 192.331 | 131.372 | 133.455 | 133.47 | 102.281 |
| Cost of Revenue
| 1,126.452 | 1,181.691 | 732.524 | 431.852 | 253.408 | 198.151 | 202.992 | 160.53 | 148.304 | 98.777 | 94.864 | 95.243 | 73.666 |
| Gross Profit
| 204.909 | 321.572 | 193.56 | 118.784 | 78.221 | 61.57 | 59.501 | 48.645 | 44.026 | 32.594 | 38.591 | 38.227 | 28.616 |
| Gross Profit Ratio
| 0.154 | 0.214 | 0.209 | 0.216 | 0.236 | 0.237 | 0.227 | 0.233 | 0.229 | 0.248 | 0.289 | 0.286 | 0.28 |
| Reseach & Development Expenses
| 109.761 | 108.098 | 64.278 | 37.901 | 23.006 | 24.56 | 22.09 | 17.759 | 0 | 0 | 0 | 10.763 | 9.847 |
| General & Administrative Expenses
| 11.384 | 29.291 | 7.42 | 5.274 | 2.952 | 2.388 | 2.82 | 7.884 | 25.505 | 22.253 | 20.913 | 17.677 | 14.838 |
| Selling & Marketing Expenses
| 8.51 | 10.751 | 22.532 | 14.746 | 14.003 | 13.215 | 14.734 | 10.92 | 7.266 | 7.094 | 7.516 | 8.079 | 8.616 |
| SG&A
| 19.894 | 89.815 | 29.952 | 20.02 | 16.956 | 15.602 | 17.555 | 18.803 | 32.771 | 29.347 | 28.429 | 25.756 | 23.454 |
| Other Expenses
| 111.281 | 0 | 14.684 | -14.498 | 4.798 | 3.301 | -0.091 | -0.411 | 0 | 0 | 3.903 | 17.079 | 11.998 |
| Operating Expenses
| 240.936 | 218.736 | 108.915 | 43.424 | 44.76 | 43.463 | 37.181 | 36.226 | 31.384 | 28.775 | 28.999 | 26.635 | 23.495 |
| Operating Income
| -36.027 | 125.8 | 78.091 | 72.494 | 28.817 | 15.944 | 7.452 | 9.131 | 10.351 | 2.609 | 6.564 | 9.04 | 1.559 |
| Operating Income Ratio
| -0.027 | 0.084 | 0.084 | 0.132 | 0.087 | 0.061 | 0.028 | 0.044 | 0.054 | 0.02 | 0.049 | 0.068 | 0.015 |
| Total Other Income Expenses Net
| -0.524 | -10.812 | -0.168 | -0.181 | -0.027 | -2.016 | -2.63 | -4.667 | 2.291 | 1.21 | 0.875 | 17.079 | 11.998 |
| Income Before Tax
| -36.551 | 114.987 | 77.863 | 72.313 | 28.79 | 9.182 | 7.361 | 8.72 | 12.642 | 3.819 | 10.467 | 26.118 | 13.557 |
| Income Before Tax Ratio
| -0.027 | 0.076 | 0.084 | 0.131 | 0.087 | 0.035 | 0.028 | 0.042 | 0.066 | 0.029 | 0.078 | 0.196 | 0.133 |
| Income Tax Expense
| -13.61 | 0.778 | -0.677 | 4.067 | 2.249 | 0.061 | 1.634 | 1.67 | 1.049 | 0.342 | 0.587 | 3.387 | 1.999 |
| Net Income
| -14.467 | 116.195 | 78.708 | 68.829 | 26.638 | 11.21 | 7.534 | 5.675 | 11.593 | 4.162 | 9.88 | 22.731 | 11.557 |
| Net Income Ratio
| -0.011 | 0.077 | 0.085 | 0.125 | 0.08 | 0.043 | 0.029 | 0.027 | 0.06 | 0.032 | 0.074 | 0.17 | 0.113 |
| EPS
| -0.068 | 0.55 | 0.52 | 0.45 | 0.18 | 0.074 | 0.12 | 0.06 | 0.19 | 0.07 | 0.1 | 0.25 | 0.12 |
| EPS Diluted
| -0.068 | 0.54 | 0.52 | 0.45 | 0.18 | 0.074 | 0.12 | 0.06 | 0.19 | 0.07 | 0.1 | 0.25 | 0.12 |
| EBITDA
| 55.16 | 175.354 | 107.767 | 88.817 | 43.782 | 23.538 | 19.128 | 21.375 | 19.613 | 10.191 | 16.165 | 16.741 | 9.637 |
| EBITDA Ratio
| 0.041 | 0.117 | 0.116 | 0.161 | 0.132 | 0.091 | 0.073 | 0.102 | 0.102 | 0.078 | 0.121 | 0.125 | 0.094 |